Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the immunohistochemistry industry, and increasing healthcare spending are key factors contributing to the high CAGR of the Immunohistochemistry Market during the forecast period.
Market Size – USD 1.88 Billion in 2019
Market Growth – CAGR of 8.6%
Market Trends – Product launches and research for advanced Immunohistochemistry
The Immunohistochemistry Market is expected to attain a valuation of USD 3.64 billion by 2027, from USD 1.88 billion in the year 2019. The market is projected to rise at an 8.6% CAGR.
Leading market players include-
Agilent Technologies; Abcam plc; Bio-Rad Laboratories, Inc.; Danaher Corporation; Thermo Fisher Scientific, Inc. Merck KGaA; Cell Signaling Technology, Inc., and PerkinElmer, Inc.
Global Market Overview
Immunohistochemistry (IHC) has been crucial to various applications related to tissue distribution of antigens, using polyclonal and monoclonal antibodies. With the ability to determine the tumor antigen’s presence, it is extensively used in the diagnosis of cancer. Combining multiple processes, such as anatomical, immunological, and biochemical, this technique aids in identifying different tissue components through the interaction of tagged antibodies with target antigens. IHC utilized by several private and public organizations for the purpose of checking distribution and localization of distinct cellular components.
With a wide array of applications in cancer diagnosis, immunohistochemistry is highly used to anticipate the therapeutic response of two important tumors like carcinoma of prostate and breast. The growth of these two tumors is under the regulation of hormones, including androgen and estrogen. Both of these regulating hormones’ specific receptors are present on their tumor cells, respectively. Tumors exhibiting increased receptor positivity have been expected to respond favorably to such hormones’ endogenous source removal. Therefore, the administration of hormonal therapy acts on lowering their levels—estrogen and androgen therapies in prostate and breast cancer, respectively.
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/2198
IHC techniques have been gaining popularity in identifying the presence of infectious elements in various tissues, using certain antibodies against RNA/DNA of the microbes, for instance in the viruses such as Hepatitis B, Cytomegalo, Hepatitis C, etc. During the process of disease, allowing the target’s visual expression in the affected tissue, the application of IHC is routinely used for disease validation. Moreover, immunohistochemistry is advantageous for detecting organisms in different cytological preparations such as sputum samples, fluids, and obtained material from the procedures of a fine needle. This is beneficial in a few situations like pneumocystis detection from the sputum of a patient who is immunocompromised and needs precise and fast confirmation regarding infection to proceed with immediate and proper therapy.
For muscular dystrophy, specific diagnosis is required due to the implications of genetically inherited disease and precise prognostication. In muscle dystrophies, abnormalities in distinct muscle proteins are detected in recent years. These abnormalities involve the location of proteins in the extracellular matrix, sarcolemma, nucleus, cytosol, and various other locations within muscle fibers. To differentiate vascular dystrophy from non-dystrophic disorders, skeletal muscle biopsy plays a crucial role, whereas immunohistochemistry aids in the establishment of specific diagnosis related to dystrophies for which the abnormalities of certain protein are known. In the past years, to detect axonal injury, the method of beta amyloid protein’s immunohistochemical staining has been validated.
High investment in healthcare in developing countries and rapid development in technology, especially in invitro industry grants several opportunities to manufacturers in terms of developing immunohistochemistry kit, reagents, and equipment. Rising incidence of chronic diseases such as cardiovascular, autoimmune, infectious, nephrological, and diabetes mellitus is the key factor responsible for the growth of the market. Rising spending in R&D and rapid shift towards advanced healthcare solutions would also propel market growth.
Further key findings from the report suggest
- Immunohistochemistry has varied applications in diagnosing chronic diseases, cancer types, neurological diseases, and the detection of malignant or benign tumor’s presence.
- Immunohistochemistry has been more beneficial than conventional techniques of enzyme staining, involving certain reactions of antigen-antibody. It is largely used in various medical research laboratories and clinical diagnostics.
- Increasing healthcare spending, the fast development of healthcare infrastructure incorporated with better care facilities and medical practice, and growing geriatric population are stimulating demand for various immunohistochemistry techniques, thus, fueling the market growth.
- The antibody sub-segment accounted for the largest share of 41.2% of the overall industry, owing to rising therapeutic antibody products’ approvals and is also anticipated to exhibit steady growth during the projection time frame.
- The sub-segment of diagnostics has been dominated the segment of applications due to the rising cases of cancer, along with other chronic diseases.
- Hospitals sub-segment is foreseen to showcase a significant rate of 7.5% of CAGR over the estimated time frame because of the growing disease prevalence along with soaring demand for healthcare facilities with modern infrastructure.
- Immunohistochemistry’s applications include diagnostics, drug testing, etc. Being crucial in the process of drug development, this technique has been popular for drug efficacy testing through the identification of target diseases’ up and down regulation.
- Immunohistochemistry kits and equipment’s high cost is hindering the growth of the market.
Early Diners Are Offered Free Customization
Get Attractive Discount on “Immunohistochemistry Market- Forecast to 2027” @ https://www.reportsanddata.com/discount-enquiry-form/2198
Market Segmentation and Regional Analysis
For this report, Reports and Data has segmented the Immunohistochemistry Market based on type, application, end-use, and region:
Type Outlook (Revenue, USD Million; 2017–2027)
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
Application Outlook (Revenue, USD Million; 2017–2027)
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
End-Use Outlook (Revenue, USD Million; 2017–2027)
- Hospitals and Diagnostic Laboratories
- Clinics
- Research Institutes
- Others
Regional Outlook (Revenue in USD Million; 2017–2027)
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- France
- UK.
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Click on the Link to Read Key Highlights of the Report and Look at Projected Trends for Years to Come: https://www.reportsanddata.com/report-detail/immunohistochemistry-market
Table of Contents:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Increased awareness and established healthcare industry
3.2. Drug testing and Diagnostics
3.3. High Prevalence of various diseases
3.4. Demand for IHC techniques By end users
Chapter 4. Immunohistochemistry Market Segmentation & Impact Analysis
4.1. Immunohistochemistry Segmentation Analysis
4.2. Immunohistochemistry Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Immunohistochemistry Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. High prevalence of target diseases across the world
4.4.1.2. Launch of novel therapeutics
4.4.2. Market restraint analysis
4.4.2.1. Lack of awareness
4.4.2.2. Availability of generics
4.5. Key opportunities prioritized
4.6. Immunohistochemistry Pricing Analysis
4.7. Industry analysis – Porter’s
4.8. Immunohistochemistry PESTEL Analysis
Continued………
Insights into Our Other Trending HealthCare Reports:
Nanoemulsions Market By Applications (Anesthetics and Antibiotics, Nonsteroidal anti-inflammatory drugs (NSAIDs), and Immunosuppressants), By Route of Administration, By Distribution Channel, And Segment Forecasts To 2027
Orthopedics Instruments Market Size, Share, Demand By Type (Sharp Instruments, Common Instruments, Bone Chisels), By Application (Arthroscopy, Soft Tissue Repair, Others), And Region – Global Forecast 2020 To 2027
Autologous Cell Therapy Product Market by Source (Bone Marrow Epidermis), By End-User (Hospitals, Ambulatory Centers, Research Centers) and By Application (Cancer, Neurodegenerative Diseases), And Segment Forecasts to 2027
Ask for your specific company profile and country level customization on reports.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Facebook | LinkedIn | Twitter | Blogs
